TopNews + Font Resize -

J&K govt approves state drug policy to promote rational use of medicines
Joseph Alexander, New Delhi | Wednesday, February 15, 2012, 08:00 Hrs  [IST]

Jammu and Kashmir Government has approved a State Drug Policy based on rational use of drugs and promising to promote local manufacturers of pharmaceuticals in line with the State Industrial Policy.

The policy, approved by the State cabinet as the culmination of a three-year long process, makes provision for an essential list of medicines which would be procured by the Government for distribution. The policy seeks to set up an expert committee called State Drug Committee to select the essential medicines and to be revised in every two years.

“In order to promote self-sufficiency, the State Government will encourage local manufacturers of pharmaceuticals in line with the State Industrial Policy. The regulatory agency shall enforce relevant guidelines on manufacture including Good Manufacturing Practices (GMP) and Good Storage Practices (GSP),” the policy said.

“To ensure safety, quality and efficacy of products, the regulatory agency shall regulate manufacture of medicinal products and cause periodic inspection of the manufacturing premises within the State,” it said.

“In all the hospitals of the State, Drugs and Therapeutic Committees shall be established and made effectively functional. These will be responsible for reviewing drug utilization and promoting rational use of drugs. A State level Drugs and Therapeutic Advisory Committee shall also be constituted to monitor the activities of the drugs and Therapeutic Committees of the hospitals,” the policy said.

“The concepts of essential drugs, rational drug use and generic prescribing shall be an integral part of basic and in-service training of health professionals. As such, these shall be incorporated in the curricula of health training institutions. All drugs shall be prescribed and dispensed only by their generic name or International Non-proprietary Name (INN) in the public sector. Regular Prescription audits shall be commissioned in public hospitals to measure the compliance in this regard,” it said.

A Drug Information Centre shall be established preferably in the Government Medical Colleges to  work in collaboration with all the stakeholders in  order to provide appropriate drug information. A State level Formulary would be published annually in line with the World Health Organization/National norms and distributed to all qualified prescribers free of cost or on subsidized rate. This will be funded through the available budget for drugs. It is recognized that activities pertaining to drug information are a right charge on the budget for procurement of drugs, according to the policy.

The State would endeavour to conduct training of drug sellers, continuing education of health care providers and consumer education. The State would endeavour to provide financial incentives to promote rational use of drugs, it said.

“The core of the concept of selection of essential medicines is that use of a limited number of carefully selected medicines based on Standard Treatment Protocols which leads to a better supply of drugs, rational prescribing, reduction in costs and finally to better health outcomes. The procurement of fewer items in larger quantities results in more price competition and economies of scale. Quality assurance, procurement, storage, distribution and dispensing are all easier with a reduced number of drugs. Although there may be about 20,000 medicines/combinations available in the market, with about 300 drugs recommended by the World Health Organization and 268 (348 list) in Essential Drugs List of Government of India, it would be possible to tackle almost all disease conditions. As far as purchase preference for Small Scale Industrial units is concerned this is already contained in the State Industrial policy. Thus it is not required to be mentioned in the State Drug Policy. As and when there are changes in the State Industrial Policy, the same would be applied to the Small Scale Industrial Units of the Pharmaceutical sector also,” it said.

The State is already considering ISM Sector at par with allopathic sector.  The Drug Policy provides for a separate State Drug Committee for the drugs of ISM sector. The said Committee would be asked to prepare Essential Drugs List for each discipline viz., Ayurveda, Unani, Homoeopathy etc. which are popular in the State, the policy said.

Comments

Daya Sagar Mar 8, 2012 11:07 PM
Outright Campaign against J&K DRUG POLICY is not in Greater Public Interest:::
The manner in which a patient is being looted could be well be seen here >. For treatment of Blood Pressure irregularities one chemical salt ( Amlodipine Besilate ) is offered in the market by different names .By brand name AMTAS-5 a 15 tablet strip is marked with MRP of Rs. 54.84. The same salt is marketed by trade name as Amodep-5 and 14 tablet strip has MRP marked as just Rs.11/=. There are many medicines in market like this. But very few doctors prescribe Amlodep in a regular course. One would ask why ? . The manner in which the drug manufacturers label their MRP for branded item and how do some doctors join hands with the seller for writing prescriptions is often discussed by people.
Question is not for making available low priced or cheaper medicines to patients. Question is for fairly displaying the MRP of the drugs. Expert institutions ( like MCI) have accused some branded drug manufactur
saleem Feb 24, 2012 10:53 AM
It is a fact that the cost difference of same drug (salt) varies many folds (across various brands) available in the market and patients are suffering definitely. I was prescribed digestive enzyme, antibiotic and pantoprazole by a physician in Srinagar, on comparing rates (with top ranking pharmaceutical brands) of various drug enzymes, antibiotic and pantoprazole in the market, i came to know that the drugs prescribed by corrupt physician were, most expensive; and irony was that those all belong to same company, these drugs were exclusively available only outside the chambers of these mal-practicing medicos. This trend of prescribing drugs of a particular company (little known company, that too having highest MRP, as compared to multinational brands) should end. Patients are suffering badly, there should be accountability and audit to these money oriented doctors and their prescriptions. I am sure, there might be many such medicos in the society who are corrupt and might be definitely
Suhail kar Feb 18, 2012 1:21 PM
It ll be nothing at the end,just these politicians want to convert their black money into legal through this policy.
This govt is not able to have Lpg cylenders to the common people.My openion to this govt is that they should first rethink on this policy.
rashid mohd Feb 15, 2012 3:15 PM
Reforms in healthcare facility
It is only after more than five decades, a drug policy was approved by the State cabinet and already people who are related to this trade directly or indirectly have started making prophecies of its failure. I personally hope that this will be the beginning for the betterment of the health care facility in our state. It is hoped that, accountability will be introduced at all stages of R&D, manufacturing, Quality assurance and quality control check, sales, distribution, purchase, prescription, dispensing and post-marketing analysis. Strengthening, security, back up facilities and empowerment of enforcement authorities would ensure the fulfillment of the objective. It is my fervent appeal to common people to have a serious look over the very rapid growth of pharmaceutical trade in our state. A serious imbalance is apparent between prosperity and accountability. The prosperity must not come at the cost of human life; it would have otherwise serious reper

Post Your Comment

 

Enquiry Form